Tracheal bioengineering

The next steps: Proceeds of an international society of cell therapy pulmonary cellular therapy signature series workshop, Paris, France, April 22, 2014

Daniel J. Weiss, Martin Elliott, Queenie Yang, Brian Poole, Martin Birchall

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

There has been significant and exciting recent progress in the development of bioengineering approaches for generating tracheal tissue that can be used for congenital and acquired tracheal diseases. This includes a growing clinical experience in both pediatric and adult patients with life-threatening tracheal diseases. However, not all of these attempts have been successful, and there is ongoing discussion and debate about the optimal approaches to be used. These include considerations of optimal materials, particularly use of synthetic versus biologic scaffolds, appropriate cellularization of the scaffolds, optimal surgical approaches and optimal measure of both clinical and biologic outcomes. To address these issues, the International Society of Cell Therapy convened a first-ever meeting of the leading clinicians and tracheal biologists, along with experts in regulatory and ethical affairs, to discuss and debate the issues. A series of recommendations are presented for how to best move the field ahead.

Original languageEnglish (US)
Pages (from-to)1601-1613
Number of pages13
JournalCytotherapy
Volume16
Issue number12
DOIs
StatePublished - Dec 1 2014
Externally publishedYes

Fingerprint

Tracheal Diseases
Bioengineering
Paris
Cell- and Tissue-Based Therapy
France
Education
Lung
Pediatrics
Therapeutics

Keywords

  • Consensus
  • Tissue-engineering
  • Trachea

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Oncology
  • Genetics(clinical)
  • Transplantation
  • Cancer Research
  • Cell Biology

Cite this

Tracheal bioengineering : The next steps: Proceeds of an international society of cell therapy pulmonary cellular therapy signature series workshop, Paris, France, April 22, 2014. / Weiss, Daniel J.; Elliott, Martin; Yang, Queenie; Poole, Brian; Birchall, Martin.

In: Cytotherapy, Vol. 16, No. 12, 01.12.2014, p. 1601-1613.

Research output: Contribution to journalArticle

Weiss, Daniel J. ; Elliott, Martin ; Yang, Queenie ; Poole, Brian ; Birchall, Martin. / Tracheal bioengineering : The next steps: Proceeds of an international society of cell therapy pulmonary cellular therapy signature series workshop, Paris, France, April 22, 2014. In: Cytotherapy. 2014 ; Vol. 16, No. 12. pp. 1601-1613.
@article{43dcf51acedd47a0b5bedb7483127add,
title = "Tracheal bioengineering: The next steps: Proceeds of an international society of cell therapy pulmonary cellular therapy signature series workshop, Paris, France, April 22, 2014",
abstract = "There has been significant and exciting recent progress in the development of bioengineering approaches for generating tracheal tissue that can be used for congenital and acquired tracheal diseases. This includes a growing clinical experience in both pediatric and adult patients with life-threatening tracheal diseases. However, not all of these attempts have been successful, and there is ongoing discussion and debate about the optimal approaches to be used. These include considerations of optimal materials, particularly use of synthetic versus biologic scaffolds, appropriate cellularization of the scaffolds, optimal surgical approaches and optimal measure of both clinical and biologic outcomes. To address these issues, the International Society of Cell Therapy convened a first-ever meeting of the leading clinicians and tracheal biologists, along with experts in regulatory and ethical affairs, to discuss and debate the issues. A series of recommendations are presented for how to best move the field ahead.",
keywords = "Consensus, Tissue-engineering, Trachea",
author = "Weiss, {Daniel J.} and Martin Elliott and Queenie Yang and Brian Poole and Martin Birchall",
year = "2014",
month = "12",
day = "1",
doi = "10.1016/j.jcyt.2014.10.012",
language = "English (US)",
volume = "16",
pages = "1601--1613",
journal = "Cytotherapy",
issn = "1465-3249",
publisher = "Informa Healthcare",
number = "12",

}

TY - JOUR

T1 - Tracheal bioengineering

T2 - The next steps: Proceeds of an international society of cell therapy pulmonary cellular therapy signature series workshop, Paris, France, April 22, 2014

AU - Weiss, Daniel J.

AU - Elliott, Martin

AU - Yang, Queenie

AU - Poole, Brian

AU - Birchall, Martin

PY - 2014/12/1

Y1 - 2014/12/1

N2 - There has been significant and exciting recent progress in the development of bioengineering approaches for generating tracheal tissue that can be used for congenital and acquired tracheal diseases. This includes a growing clinical experience in both pediatric and adult patients with life-threatening tracheal diseases. However, not all of these attempts have been successful, and there is ongoing discussion and debate about the optimal approaches to be used. These include considerations of optimal materials, particularly use of synthetic versus biologic scaffolds, appropriate cellularization of the scaffolds, optimal surgical approaches and optimal measure of both clinical and biologic outcomes. To address these issues, the International Society of Cell Therapy convened a first-ever meeting of the leading clinicians and tracheal biologists, along with experts in regulatory and ethical affairs, to discuss and debate the issues. A series of recommendations are presented for how to best move the field ahead.

AB - There has been significant and exciting recent progress in the development of bioengineering approaches for generating tracheal tissue that can be used for congenital and acquired tracheal diseases. This includes a growing clinical experience in both pediatric and adult patients with life-threatening tracheal diseases. However, not all of these attempts have been successful, and there is ongoing discussion and debate about the optimal approaches to be used. These include considerations of optimal materials, particularly use of synthetic versus biologic scaffolds, appropriate cellularization of the scaffolds, optimal surgical approaches and optimal measure of both clinical and biologic outcomes. To address these issues, the International Society of Cell Therapy convened a first-ever meeting of the leading clinicians and tracheal biologists, along with experts in regulatory and ethical affairs, to discuss and debate the issues. A series of recommendations are presented for how to best move the field ahead.

KW - Consensus

KW - Tissue-engineering

KW - Trachea

UR - http://www.scopus.com/inward/record.url?scp=84911893977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84911893977&partnerID=8YFLogxK

U2 - 10.1016/j.jcyt.2014.10.012

DO - 10.1016/j.jcyt.2014.10.012

M3 - Article

VL - 16

SP - 1601

EP - 1613

JO - Cytotherapy

JF - Cytotherapy

SN - 1465-3249

IS - 12

ER -